Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Comment by cornwallison Apr 30, 2019 11:10am
94 Views
Post# 29688651

RE:So

RE:So
There has been some dilution since then. These are taken from some of the MD&As -
- "As of February 27, 2018, the total number of issued and outstanding common shares is 72,279,970 common shares."
- "As of April 2, 2018, the total number of issued and outstanding common shares is 92,681,632 common shares."
- "As of February 28, 2019, the total number of issued and outstanding common shares is 113,084,720 common shares."
- "As of April 1, 2019, the total number of issued and outstanding common shares is 116,608,552 common shares."
 
What's that, about 60% more shares between March 2018 and April 2019?
 
There was some recent discussion here about the debentures and how they might concern some investors, too.
 
Also, we can't forget that the licensing process was painful, even if the challenges were mostly outside of RQB's control, and even if the situation is somewhat better now. Things have progressed a lot slower than I thought they would have a year ago, even with delays and setbacks being expected then, for example. I'm probably not alone in thinking this.
 
I think there's also uncertainty regarding the status of Port Mellon, Fort McMurray, the Bloomera/Lore branding, Elephant Extracts, 1 Life, Edmonton retail, Bonify, and the other initiatives that have been announced but that we haven't really heard much about since. Maybe some good news regarding these would help bring some attention to RQB.
<< Previous
Bullboard Posts
Next >>